Bone Biologics files prospectus supplement for ATM offering of up to $1.064M in common stock

Bone Biologics Corp

Filing covers up to $1,064,000 shares of common stock sold at market through H.C. Wainwright as sales agent.
Company previously sold $1.7M under prior shelf; new supplement uses Form S-3 declared effective Sept 2025.
Proceeds from ATM offering will be used for general corporate purposes (not specified further).
Legal opinion of Harter Secrest & Emery LLP on share legality filed as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.